25 May 2013
Keywords: Aesica, UCB, Manufacturing plants, APIs
Article | 17 December 2010
UK-based Aesica Pharmaceuticals, a developer and manufacturer of active ingredients, has signed agreements ahead of acquiring three manufacturing sites in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 December 2010
15 December 2010
24 May 2013
© 2013 thepharmaletter.com